HKTB Extends Hong Kong Neighbourhoods to Launch West Kowloon for Promoting Art and Culture Tourism of the Neighbourhood
                            The Indian Council of Medical Research recently approved CoviFind, produced by Meril, the medical device company owned by the Bilakhia Group. CoviFind is a self-use Rapid Antigen Test for COVID-19. It is capable of detecting the SARS-CoV-2 virus in infected individuals within 15 minutes.
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.
Follow us on:
Business Wire India
The Business Wire India news distribution platform ensures that your news is disseminated instantaneously through key information systems.

Public Reaction